Literature DB >> 23261795

The basis of the substrate specificity of the epsilon isoform of human diacylglycerol kinase is not a consequence of competing hydrolysis of ATP.

Aaron Prodeus1, Bob Berno, Matthew K Topham, Richard M Epand.   

Abstract

The diacylglycerol kinase from E. coli transfers some of the γ-phosphate of ATP to water as well as to diacylglycerol. We also demonstrate that glycerol can act as an acceptor for the phosphate of ATP. We have compared this behavior with that of the only mammalian isoform of diacylglycerol kinase that exhibits acyl chain specificity, i.e. DGKɛ. The purpose of the study was to determine if differences in the competition between ATPase activity and lipid phosphorylation could contribute to the observed acyl chain specificity with different diacylglycerols. Neither with the highly specific substrate of DGKɛ, 1-stearoyl-2-arachidonoyl glycerol, nor with a less specific substrate, 1-stearoyl-2-linoleoyl glycerol, is there any evidence for ATP hydrolysis accompanying substrate phosphorylation. Thus, at least for this isoform of diacylglycerol kinase, water does not compete with diacylglycerol as an acceptor of the γ-phosphate of ATP. The results demonstrate that the substrate specificity of mammalian DGKɛ is not a consequence of different degrees of ATP hydrolysis in the presence of different species of diacylglycerol. 2012 Elsevier Ireland Ltd. All rights reserved

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23261795     DOI: 10.1016/j.chemphyslip.2012.11.006

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  2 in total

Review 1.  Diacylglycerol Kinase-ε: Properties and Biological Roles.

Authors:  Richard M Epand; Vincent So; William Jennings; Bijendra Khadka; Radhey S Gupta; Mathieu Lemaire
Journal:  Front Cell Dev Biol       Date:  2016-10-18

2.  Bacterial expression strategies for several Sus scrofa diacylglycerol kinase alpha constructs: solubility challenges.

Authors:  Elizabeth J Petro; Daniel M Raben
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.